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Background. Evaluation of anisocoria including pharmacological testing for Horner’s syndrome in the pediatric population is
challenging in view of potential serious underlying disease. We describe cocaine test results, outcome of systemic investigation,
and long-term follow-up in children with anisocoria. Methods. Retrospective review of medical records and phone interview of
consecutive pediatric patients (<18 years old) who underwent cocaine testing from August 2007 to July 2015 at a tertiary
referral centre. Results. A total of 35 patients were included with a positive, negative, or inconclusive cocaine test in 12/35, 19/35,
and 4/35, respectively. Systemic investigation was performed in 11 of the patients with a positive and in 2 of the patients with an
inconclusive cocaine test result. Mediastinal Hodgkin lymphoma was found in one patient with an inconclusive cocaine test
result. Two other cases were presumably related to birth trauma and surgical trauma. None of the other children further
developed any pathology during the follow-up period of 34.8 months (range 0–106.6). Conclusions. In most children with
anisocoria and a positive cocaine test result, systemic investigation did not reveal any underlying etiology. The only malignant
disease was diagnosed in a patient with a suspicion of Horner’s syndrome but with an inconclusive cocaine test result in our cohort.
1. Introduction
Anisocoria in children is a fairly common ﬁnding. Visible
anisocoria of >0.4mm was present in 19.1% of children in a
study based on measurements with an automated photoscre-
ener in a clinical pediatric ophthalmology population, whilst
anisocoria of >0.9mm was found only in 2.3% [1].
Anisocoria with pupillary miosis on the aﬀected side
along with ptosis is the hallmark sign of Horner’s syndrome.
Iris heterochromia, dilation lag, anhidrosis, and harlequin
sign may concurrently be present [2, 3]. Cocaine eye drops
can be used to conﬁrm the clinical diagnosis of Horner’s
syndrome. A resulting anisocoria value of at least 0.8mm
was eﬀective in separating normal subjects from patients with
oculosympathetic dysfunction in adults [4]. Hydroxyamphe-
tamine drops have historically been used to distinguish
preganglionic from postganglionic disease. However, as
hydroxyamphetamine is usually not readily available and
testing is not reliable in children due to possible transsynaptic
degeneration [5], localizing tests have widely been replaced
by magnetic resonance imaging of the head, neck, and upper
chest [6].
Though the diagnosis of Horner’s syndrome is rare in
pediatric patients, potential serious underlying etiologies
raise concern. Smith et al. found an incidence of pediatric
Horner’s syndrome of 1.42 per 100,000 patients younger than
19 years in their population-based study [7]. Lesions can be
found along the oculosympathetic pathway caused by birth
trauma, surgical procedures, benign and malignant neopla-
sia, lymphadenopathy, vascular and cerebral malformations,
carotid artery thrombosis, or dissection in pediatric patients
[6–15]. Neuroblastoma is the most common occult malig-
nancy to be associated with pediatric Horner’s syndrome.
The prevalence of underlying mass lesions in cases of
Horner’s syndrome without previously identiﬁed etiologies
diﬀers from 0% to up to 21% in diﬀerent studies [7–10, 16,
17]. Musarella et al. found Horner’s syndrome in 14 of 405
(3.5%) patients with neuroblastoma, while it was the
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presenting sign in 9 (2.2%) of them [18]. As a result, there is a
controversy regarding the need and extent of systemic
investigation in children with Horner’s syndrome [6–10].
We report results of cocaine testing and underlying etiol-
ogies as well as follow-up data in a cohort of patients younger
than 18 years with anisocoria during an 8-year period.
2. Patients and Methods
The study was conducted at a tertiary referral centre
(Department of Ophthalmology, University Hospital Zurich,
Switzerland). At our institution, any use of cocaine eye drops
is recorded in a separate chart. From this record, all pediatric
patients (<18 years old) that underwent cocaine testing from
August 2007 to July 2015 were included. Patients’ medical
histories, including birth history, prior surgery, age at onset
and age at presentation, manifesting signs, results of cocaine
testing as well as results of subsequent physical examination,
catecholamine studies, and imaging studies were retrospec-
tively reviewed. To collect follow-up data, the last follow-up
visits were analyzed or parents or patients were contacted
by phone regarding anisocoria and health status.
Positive cocaine tests were deﬁned by an ophthalmologist-
observed increase in anisocoria and/or resulting anisocoria
of >1mm following administration of cocaine eye drops
(2.5%, 5%, or 10% depending on age) to both eyes after 30
to 60 minutes. If cocaine drops did not show appropriate
dilation of either pupil, the test result was classiﬁed as
inconclusive. Negative test results were deﬁned as a decrease
in anisocoria and/or resulting anisocoria of <1mm.
The study was approved by the local ethics committee
(KEK-ZH-Nr. 2016-0004) and written informed consent
was obtained.
3. Results
A total of 38 patients younger than 18 years that underwent
cocaine testing during the 8-year study period were eligible.
No written informed consent was available in 3 patients,
who were not included in the analysis. Median age at ﬁrst
notice of anisocoria was 3 months (range 0–202 months),
and median age at presentation was 8 months (range 1–214
months) (Table 1). In 11 patients, anisocoria was noticed
within the ﬁrst month of life.
Anisocoria was conﬁrmed in all 35 patients andwas noted
to be greater in dark than in bright condition in 22 patients. In
the remaining cases, either diﬀerence in pupil sizes remained
equal for dark and light or was not recorded. 8 cases had
ptosis or possible ptosis on the side of the smaller pupil. In
one patient with a negative cocaine test, ptosis was attribut-
able to contact lens wear. Ipsilateral iris hypochromia was
noted in 2 cases, and a harlequin sign was reported in 1 case.
Additional ophthalmologic ﬁndings included an anterior
polar cataract on the aﬀected side (n = 1), a brief episode of
ocular ﬂutter (n = 1) and pendular nystagmus along with
horizontal gaze palsy (n = 1).
Cocaine test result was positive in 12 (31.4%), inconclu-
sive in 4 (11.4%), and negative in 19 (57.1%) patients. Further
evaluation by a pediatrician including physical examination,
urine catecholamine testing, and imaging was initiated in
10/11 with a positive and 3/4 with an inconclusive test result
as summarized in Table 2. In patient number 12 with an
inconclusive test result, magnetic resonance imaging (MRI)
of the head was performed for investigation of his abnormal
eye movements. He was later diagnosed with compound het-
erozygous ROBO3 mutation [19]. Patient number 23, who
had anisocoria greater in light than in dark, had a positive
cocaine test in his left eye but also showed supersensitivity
to spersacarpine 0.2% in his right eye. A parasympathetic
innervation deﬁcit in his right eye was assumed and no
systemic workup was performed. No further systemic inves-
tigation was initiated in patient number 34 despite an incon-
clusive cocaine test result as anisocoria was longstanding.
Mediastinal Hodgkin’s disease was found as an underlying
etiology in one patient. No associated pathology was revealed
in any other patient following systemic investigation. In
two cases with a positive cocaine test result, birth trauma
(n = 1) and surgical intervention (n = 1) were retrospec-
tively assumed as causative factors.
Follow-up data were available in all but three patients
with positive, inconclusive, or negative cocaine test results
with a mean follow-up time of 34.8 months (range 0–106.6
months). No additional systemic disease related to anisocoria
was reported in any of these patients.
4. Discussion
A majority of children in our case series was evaluated for
isolated anisocoria. Many of these patients were noted to have
anisocoria greater at dark than in light, which is a classical
ﬁnding in Horner’s syndrome. However, it is also frequently
seen in physiological anisocoria [2]. Other clinical signs of
possible Horner’s syndrome were noted in only 8 patients.
However, subtle ptosis may be diﬃcult to assess in infants
and small children and Horner’s syndromemay exist without
clinically detectable ptosis in up to 13% in adults [20].
Table 1: Summary of patient data.
Cocaine test
result
Number of
patients
(follow-up)
Median age at
ﬁrst notice
(months) (range)
Congenital
onset (0-1
month of life)
Median age at
presentation
(months) (range)
Ptosis on
miotic
side
Possible
ptosis on
miotic side
Iris
heterochromia
Harlequin
sign
Total 35 (32) 3.0 (0–202) 11 8.0 (1–214) 4 4 2 1
Positive 12 (11) 1.25 (0–115) 6 5.5 (1–133) 1 1 1 1
Inconclusive 4 (4) 4.5 (3–181) 0 8.0 (6–183) 2 1 0 0
Negative 19 (17) 3.0 (0–202) 5 10.0 (2–214) 1 2 1 0
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All except one of the children with a positive cocaine test
result in our series were referred for systemic evaluation
including MRI, which did not reveal any underlying systemic
pathology. A history of birth trauma or surgery was a rare
explanation in our study. In other studies, the portion of
Horner’s syndrome related to birth trauma or previous
surgery was signiﬁcantly higher [8, 9]. It is possible that some
of the patients with a positive cocaine test in our study had
physiological anisocoria with a false-positive test result rather
than true Horner’s syndrome which may be an explanation
for the relatively few identiﬁable causes found. Cocaine
testing is susceptible to diﬀerent sources of error such as
pharmacological quality, dilution procedure, and accuracy
of drop instillation. The alpha-adrenergic substance apraclo-
nidine has increasingly been used in the diagnosis of
Horner’s syndrome in order to overcome these limitations
in adults and children [21, 22]. However, caution is warranted
as central nervous system adverse eﬀects have been reported
following diagnostic use of apraclonidine in infants [23].
More than half of patients had a negative test result
(n = 19). No further investigation was recommended in these
cases which was in retrospect the correct decision.
The only serious underlying pathology in our study was
detected in a patient with an inconclusive test result. However,
she did have new onset of anisocoria and ptosis suggestive of
Horner’s syndrome as well as concurrent weight loss which
prompted further investigation and led to the diagnosis of
mediastinalHodgkin’s disease. Similarly, in a recent case series
of26 infantswithanisocoria, onlyaminoritypresentedwithan
additional localizing sign suchasptosis andunderlyingdisease
was found exclusively in some of these cases [17].
The diagnostic approach in infants and children with
anisocoria remains a clinical challenge. Physiological aniso-
coria is frequent but a diagnosis of Horner’s syndrome is
associated with potentially serious systemic conditions. Our
results from a real-life setting highlight the need for careful
clinical assessment of anisocoria and clinical features
potentially associated with Horner’s syndrome rather than
depending on pharmacological testing alone.
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